| abstract |
Reagents which regulate human LGR4-like G protein-coupled receptor (LGR4-like GPCR) and reagents which bind to human LGR4-like GPCR gene products can play a role in preventing, ameliorating, or correcting dysfunctions or diseases in which G protein-coupled receptors are implicated including, but not limited to, obesity and diseases related to obesity, cancer, diabetes, osteoporosis, anxiety, depression, hypertension, migraine, compulsive disorders, schizophrenia, autism, neurodegenerative disorders, such as Alzheimer's disease, Parkinsonism, and Huntington's chorea, and cancer chemotherapy-induced vomiting. |